|
Today’s climate in the pharmacoeconomic arena, characterized by sinking profit margins, redistributions of market shares and increasing competition, all highlight an urgent need to identify clear strategies for the future of pharmaceutical pricing and reimbursement. SMi is proud to present its 14th Annual European Pharmaceutical Pricing and Reimbursement Conference, which will bring together the leading figures in the field to address the questions of uncertainty for the future. With an exceptional speaker line-up including: , · Dr Deborah Williams, Director, Government Affairs and Public Policy, Baxter · Dr Slawomir Chomik, Area Director, Central Europe, Solvay · Dr Marta Wielondek, Brand Director, Hemostaseology, Novartis · Susana Murteira, Head, Pricing & Reimbursement, Lundbeck · Prof Fabrizio Gianfrate, Health Economics, University of Ferrara · Dr Janice Haigh, Director, European Price and Trade, Astellas expect to hear the latest on European pricing policy and strategy, market analyses and the impact of healthcare bodies on European P&R. Who should attend: Directors, Heads and Managers of: - Pricing and Reimbursement
- Strategic Pricing
- Marketing/Commercial Pricing
- Price Monitoring
- Reimbursement & Access
- Health Economics
- Economic Affairs
- Outcomes Research
- Corporate/Regulatory/Government Affairs
- Pharmaceutical Policy
- Advisor/Analyst
- Brand Management
- Sales & Marketing
- Business Development
Benefits of attending: - Optimise your pricing and reimbursement strategy
- Discover the impact of parallel trade and generics
- Analyze how health economics and outcomes research can help to predict pricing issues
- Identify regional variations in pricing and reimbursement across Europe
- Understand how the market influences, and is influenced, by pharmaceutical pricing
Delegates from the following organisations have registered to attend:
- Sanofi Aventis
- Popewood Head and associates
- Elan Drug Delivery
- Alcon Laboratories (U K) Ltd
- LFB Biomedicaments
- ALMIRALL
- The Medicines Company
- Lundbeck
- Teijin Pharma Limited
- Glaxosmithkline Gmb H & Co K G
- Novo Nordisk
- Berlin-Chemie Menarini Group
- Stiefel Laboratories Inc
- GSK
- Kyowa Hakko Kirin UK Ltd
- Nycomed
- APM Health Europe
- Fresenius Medical Care GmbH
- Biogen IDEC International GmbH
- Novartis Pharma AG
- Lloyds Pharmacy
- Orion Pharma
- Genzyme Corporation
- Swedish Orphan A B
- MME LLC
| |
|
Events Home Page
 logo.gif)
